TheGRK2Promoter Is Regulated by Early‐Growth Response Transcription FactorEGR‐1

Authors:

Abstract
The G‐protein‐coupled receptor kinase 2 (GRK2) plays a major role in cardiovascular diseases, and its expression is increased in heart failure. However, only little is known about factors being involved in up‐regulation ofGRK2 expression through transcriptional regulation of its promoter. Since the transcription factor early‐growth response 1 (EGR‐1) is also up‐regulated in patients with heart failure, we tested the hypothesis thatEGR‐1 regulatesGRK2transcription. Stimulation of immortalized rat cardiomyocytes (H9c2) with phorbol 12‐myristate 13‐acetate (PMA) resulted in up‐regulation ofEgr‐1and subsequently ofGrk2mRNAexpression, with maximumGrk2expression (p= 0.008) 5 hr afterPMAstimulation and being abolished by actinomycin D, indicating a transcriptional mechanism. To identify naturally occurring variants affecting promoter transcriptional activity, we identified a novel G(‐43)A polymorphism (rs182084609), which surrounded a putativeEGR‐1‐binding site. While the minor A allele frequency was rare (0.02), this variant was used to explore regulation byEGR‐1 and promoter construct with altered alleles at nt‐43 were subjected of reporter assays in human embryonic kidney cells (Hek293). Here,EGR‐1 over‐expression resulted in a more than twofold increase inGRK2promoter activity but only in the presence of the G‐allele (p= 0.04). In electrophoretic mobility shift assays,EGR‐1 over‐expression resulted in a specific binding of transcription factors only to the G oligonucleotide. Finally,EGR‐1 over‐expression resulted in increasedGRK2mRNAexpression (p= 0.03). We identifiedEGR‐1 as a regulator ofGRK2transcription. Suppression ofGRK2 expression by inhibition ofEGR‐1 binding toGRK2might be a promising approach to mitigate adrenergic desensitization.

This publication has 41 references indexed in Scilit: